Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults
- PMID:19281939
- PMCID: PMC2738590
- DOI: 10.1016/j.amjopharm.2009.02.006
Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults
Abstract
Background: Depressive symptoms, fatigue, and apathy are common symptoms among medically ill older adults and patients with advanced disease, and have been associated with morbidity and mortality. Methylphenidate has been used to treat these symptoms because of its rapid effect. Despite the long history of methylphenidate use for the treatment of depressive symptoms, fatigue, and apathy, there is little definitive evidence to support its use.
Objective: The aim of this paper was to review the efficacy and tolerability of methylphenidate in the treatment of depressive symptoms, fatigue, and apathy in medically ill older adults and adults receiving palliative care.
Methods: English-language articles presenting systematic reviews, clinical trials, or case series describing the use of methylphenidate for the treatment of depressive symptoms, fatigue, or apathy in medically ill older adults or adults receiving palliative care were identified. The key words methylphenidate and either depressive, depression, fatigue, or apathy were used to search the Cochrane Database, MEDLINE, PsycINFO, and International Pharmaceutical Abstracts. Included articles addressed depressive symptoms, fatigue, or apathy in (1) older adults (generally, age > or =65 years), particularly those with comorbid medical illness; (2) adults receiving palliative care; and (3) adults with other chronic illnesses. I excluded articles regarding treatment of depression in healthy young adults; bipolar disorder and attention-deficit/hyperactivity disorder; and narcolepsy, chronic fatigue syndrome, and related disorders.
Results: A total of 19 controlled trials of methylphenidate in medically ill older adults or patients in palliative care were identified. Unfortunately, their conflicting results, small sample sizes, and poor methodologic quality limited the ability to draw inferences regarding the efficacy of methylphenidate, although evidence of tolerability was stronger. The available evidence suggests possible effectiveness of methylphenidate for depressive symptoms, fatigue, and apathy in various medically ill populations.
Conclusion: In the absence of definitive evidence of effectiveness, trials of low-dose methylphenidate in medically ill adults with depression, fatigue, or apathy, with monitoring for response and adverse effects, are appropriate.
Similar articles
- Depression in the medically ill elderly: a focus on methylphenidate.Emptage RE, Semla TP.Emptage RE, et al.Ann Pharmacother. 1996 Feb;30(2):151-7. doi: 10.1177/106002809603000209.Ann Pharmacother. 1996.PMID:8835049Review.
- Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.Epstein T, Patsopoulos NA, Weiser M.Epstein T, et al.Cochrane Database Syst Rev. 2014 Sep 18;(9):CD005041. doi: 10.1002/14651858.CD005041.pub2.Cochrane Database Syst Rev. 2014.Update in:Cochrane Database Syst Rev. 2016 May 26;(5):CD005041. doi: 10.1002/14651858.CD005041.pub3.PMID:25230710Updated.Review.
- Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: a four-week, randomized, double-blinded, placebo-controlled study.Ng CG, Boks MP, Roes KC, Zainal NZ, Sulaiman AH, Tan SB, de Wit NJ.Ng CG, et al.Eur Neuropsychopharmacol. 2014 Apr;24(4):491-8. doi: 10.1016/j.euroneuro.2014.01.016. Epub 2014 Jan 20.Eur Neuropsychopharmacol. 2014.PMID:24503279Clinical Trial.
- Methylphenidate for depression in the elderly, medically ill patient.Frye CB.Frye CB.Am J Health Syst Pharm. 1997 Nov 1;54(21):2510-1. doi: 10.1093/ajhp/54.21.2510.Am J Health Syst Pharm. 1997.PMID:9359961No abstract available.
- Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.Kerr CW, Drake J, Milch RA, Brazeau DA, Skretny JA, Brazeau GA, Donnelly JP.Kerr CW, et al.J Pain Symptom Manage. 2012 Jan;43(1):68-77. doi: 10.1016/j.jpainsymman.2011.03.026.J Pain Symptom Manage. 2012.PMID:22208450Clinical Trial.
Cited by
- The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.Pottegård A, Bjerregaard BK, Glintborg D, Kortegaard LS, Hallas J, Moreno SI.Pottegård A, et al.Eur J Clin Pharmacol. 2013 Mar;69(3):589-98. doi: 10.1007/s00228-012-1344-0. Epub 2012 Jul 19.Eur J Clin Pharmacol. 2013.PMID:22811260
- A Review of Psychostimulants for Adults With Depression.Pary R, Scarff JR, Jijakli A, Tobias C, Lippmann S.Pary R, et al.Fed Pract. 2015 Apr;32(Suppl 3):30S-37S.Fed Pract. 2015.PMID:30766117Free PMC article.
- How should we manage information needs, family anxiety, depression, and breathlessness for those affected by advanced disease: development of a Clinical Decision Support Tool using a Delphi design.van Vliet LM, Harding R, Bausewein C, Payne S, Higginson IJ; EUROIMPACT.van Vliet LM, et al.BMC Med. 2015 Oct 13;13:263. doi: 10.1186/s12916-015-0449-6.BMC Med. 2015.PMID:26464185Free PMC article.
- Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review.Westover AN, Halm EA.Westover AN, et al.BMC Cardiovasc Disord. 2012 Jun 9;12:41. doi: 10.1186/1471-2261-12-41.BMC Cardiovasc Disord. 2012.PMID:22682429Free PMC article.Review.
- Pathophysiology and Current Drug Treatments for Post-Stroke Depression: A Review.Frank D, Gruenbaum BF, Zlotnik A, Semyonov M, Frenkel A, Boyko M.Frank D, et al.Int J Mol Sci. 2022 Dec 1;23(23):15114. doi: 10.3390/ijms232315114.Int J Mol Sci. 2022.PMID:36499434Free PMC article.Review.
References
- Koenig HG. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry. 1998;20:29–43. - PubMed
- Hotopf M, Chidgey J, Addington-Hall J, Ly KL. Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med. 2002;16:81–97. - PubMed
- Covinsky KE, Fortinsky RH, Palmer RM, Kresevic DM, Landefeld CS. Relation between symptoms of depression and health status outcomes in acutely ill hospitalized older persons. Ann Intern Med. 1997;126:417–425. [see comment] - PubMed
- Covinsky KE, Kahana E, Chin MH, Palmer RM, Fortinsky RH, Landefeld CS. Depressive Symptoms and 3-Year Mortality in Older Hospitalized Medical Patients. Ann Intern Med. 1999;130:563–569. - PubMed
- Kempen GI, Sanderman R, Scaf-Klomp W, Ormel J. The role of depressive symptoms in recovery from injuries to the extremities in older persons. A prospective study. Int J Geriatr Psychiatry. 2003;18:14–22. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Medical